Luminas, Baby Boy .

HRN: 29-25-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2026
AMPICILLIN 250MG (VIAL)
07/13/2026
07/19/2026
IV
150mg
Q12
PROM
Checking Final Appropriateness 
07/13/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
07/13/2026
07/19/2026
IV
15mg
Q24
PROM
Checking Final Appropriateness 
07/15/2026
CEFOTAXIME 500MG (VIAL)
07/15/2026
07/21/2026
IV
150mg
Q12H
Neonatal Sepsis
Checking Final Appropriateness 
07/15/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/15/2026
07/21/2026
IV
40mg
Q24H
Neonatal Sepsis
Checking Final Appropriateness 
07/16/2026
CEFTRIAXONE 1G (VIAL)
07/16/2026
07/16/2026
IVT
300mg
Loading Dose
Sepsis, T/c Klebsiella Infection
Checking Final Appropriateness 
07/16/2026
CEFTRIAXONE 1G (VIAL)
07/16/2026
07/22/2026
IVT
240mg
Q24H
Sepsis, T/c Klebsiella Infection
Checking Final Appropriateness 
07/20/2026
MUPIROCIN 2%, 15G (TUBE)
07/20/2026
07/27/2026
TOPICAL
As Needed
BID
IV Phlebitis
Remove - Pending Acceptance
07/21/2026
CIPROFLOXACIN 500MG (TAB)
07/21/2026
07/27/2026
PO
30mg/pptab
Q12
Sepsis
Remove - Pending Acceptance
07/26/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/26/2026
08/02/2026
IV
36mg, Then 18mg
Q 24
PSNB
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: